Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive...

Por Gajda, M., Camara, O., Oppel, S., Kroll, T., Jörke, C., Krauspe, S., Hammer, U., Rabenstein, C., Untch, M., Runnebaum, I. B., Pachmann, K.
Publicado em 2008